These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
909 related articles for article (PubMed ID: 25132759)
21. MicroRNAs as promising biomarkers for gastric cancer. Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330 [TBL] [Abstract][Full Text] [Related]
23. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. da Silva Oliveira KC; Thomaz Araújo TM; Albuquerque CI; Barata GA; Gigek CO; Leal MF; Wisnieski F; Rodrigues Mello Junior FA; Khayat AS; de Assumpção PP; Rodriguez Burbano RM; Smith MC; Calcagno DQ World J Gastroenterol; 2016 Sep; 22(35):7951-62. PubMed ID: 27672290 [TBL] [Abstract][Full Text] [Related]
24. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules. Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019 [TBL] [Abstract][Full Text] [Related]
25. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. Cheng J; Zhuo H; Xu M; Wang L; Xu H; Peng J; Hou J; Lin L; Cai J J Transl Med; 2018 Aug; 16(1):216. PubMed ID: 30068360 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling. Song J; Guan Z; Li M; Sha S; Song C; Gao Z; Zhao Y Oncol Res; 2018 Jul; 26(6):847-856. PubMed ID: 28800791 [TBL] [Abstract][Full Text] [Related]
27. Complex interactions between microRNAs and hepatitis B/C viruses. Fan HX; Tang H World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078 [TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. To KK; Tong CW; Wu M; Cho WC World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463 [TBL] [Abstract][Full Text] [Related]
29. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer. Shekari N; Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T Anticancer Agents Med Chem; 2019; 19(3):304-309. PubMed ID: 30543177 [TBL] [Abstract][Full Text] [Related]
30. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Li X; Zhang Y; Zhang H; Liu X; Gong T; Li M; Sun L; Ji G; Shi Y; Han Z; Han S; Nie Y; Chen X; Zhao Q; Ding J; Wu K; Daiming F Mol Cancer Res; 2011 Jul; 9(7):824-33. PubMed ID: 21628394 [TBL] [Abstract][Full Text] [Related]
31. Altered MiRNA expression in gastric cancer: a systematic review and meta-analysis. Wang QX; Zhu YQ; Zhang H; Xiao J Cell Physiol Biochem; 2015; 35(3):933-44. PubMed ID: 25633747 [TBL] [Abstract][Full Text] [Related]
32. MicroRNAs in oral cancer: Biomarkers with clinical potential. Yete S; Saranath D Oral Oncol; 2020 Nov; 110():105002. PubMed ID: 32949853 [TBL] [Abstract][Full Text] [Related]
33. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis. Chen Z; Li Z; Soutto M; Wang W; Piazuelo MB; Zhu S; Guo Y; Maturana MJ; Corvalan AH; Chen X; Xu Z; El-Rifai WM Gastroenterology; 2019 Mar; 156(4):1127-1139.e8. PubMed ID: 30502323 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. Matuszcak C; Haier J; Hummel R; Lindner K World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504 [TBL] [Abstract][Full Text] [Related]
35. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225 [TBL] [Abstract][Full Text] [Related]
36. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer. Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651 [TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524 [TBL] [Abstract][Full Text] [Related]
39. High expression of Du WB; Lin CH; Chen WB World J Gastroenterol; 2019 Aug; 25(31):4452-4467. PubMed ID: 31496624 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Sakamoto N; Naito Y; Oue N; Sentani K; Uraoka N; Oo HZ; Yanagihara K; Aoyagi K; Sasaki H; Yasui W Cancer Sci; 2014 Feb; 105(2):236-43. PubMed ID: 24283384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]